FOXO Technologies to spin off its epigenetics subsidiary

2 hours ago 1
  • FOXO Technologies (NYSE:FOXO) said on Thursday that its board has approved pursuing the spin-off of its FOXO Labs subsidiary that is focused on the development of its epigenetics business.
  • The Epigenetics subsidiary has been serving as a pioneer in the

Recommended For You

More Trending News

Read Entire Article